APA

Galés C., Poirot M., Taillefer J., Maigret B., Martinez J., Moroder L., Escrieut C., Pradayrol L., Fourmy D. & Silvente-Poirot S. (20030513). Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. : Molecular pharmacology.

Chicago

Galés Céline, Poirot Marc, Taillefer Julien, Maigret Bernard, Martinez Jean, Moroder Luis, Escrieut Chantal, Pradayrol Lucien, Fourmy Daniel and Silvente-Poirot Sandrine. 20030513. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. : Molecular pharmacology.

Harvard

Galés C., Poirot M., Taillefer J., Maigret B., Martinez J., Moroder L., Escrieut C., Pradayrol L., Fourmy D. and Silvente-Poirot S. (20030513). Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. : Molecular pharmacology.

MLA

Galés Céline, Poirot Marc, Taillefer Julien, Maigret Bernard, Martinez Jean, Moroder Luis, Escrieut Chantal, Pradayrol Lucien, Fourmy Daniel and Silvente-Poirot Sandrine. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. : Molecular pharmacology. 20030513.